Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies

Blood

Volumn 88, Issue 9, 1996, Pages 3446-3450

  Bi, Lei ^b   Sarkar, Rita ^b   Naas, Thierry ^b   Lawler, Ann M ^b   Pain, Jayashree ^b   Shumaker, Sally L ^b   Bedian, Vahe ^b   Kazazian Jr , Haig H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8; MESSENGER RNA; MONOCLONAL ANTIBODY; RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE TARGETING; GENE THERAPY; HEMOPHILIA A; IMMUNOBLOTTING; INTRON; LIVER; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING;

EID: 0029957538     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3446.bloodjournal8893446     Document Type: Article

References (16)

1. Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster B, Coe ML, Knuston GL, Fass DN, Hewick RM: Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312:342, 1984
2. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM: Characterization of the human factor Vin gene. Nature 312:326, 1984
3. Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KL, Delwart E, Tuddenham EGD, Vehar GA, Lawn RM: Expression of active human factor VIII from recombinant DNA clones. Nature 312:330, 1984
4. Kaufman RJ, Wasley LC, Dorner AJ: Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 263:6352, 1988
5. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J: Inversion disrupting the factor VIII gene are a common cause of severe hemophilia A. Nature Genet 5:236, 1993
6. Hoeben RC, Fallaux FJ, Van Tilburg NH, Cramer SJ, Van Ormondt H, Briet E, Van Dereb AJ: Toward gene therapy for hemophilia A: long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice. Human Gene Ther 4:179, 1993
7. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman O, Finegold M, Thompson AR, Read MS, Brinkhaus KM, Woo, SLC: In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262:117, 1993
8. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genet 10:119, 1995
9. Rosén S: Assay of factor VIII:C with a chromogenic substrate. Scand J Haemotol 40:139, 1984 (suppl 33)
10. Chomczymski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
11. Akowitz A, Manuelidis L: A novel cDNA/PCR strategy for efficient cloning of small amounts of undefined RNA. Gene 81:295, 1989
12. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP: Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85:5698, 1988
13. Lane R, Crissman R, Ginn S: High efficiency fusion procedure for producing monoclonal antibodies against weak immunogens. Methods Enzymol 121:183, 1986
14. Harlow ED Lane D: Antibodies, A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
15. Brodniewicz-Proba T, Beauregard D: Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability. Vox Sang 52:10, 1987
16. Levinson B, Kenwrick S, Gamel P, Fisher K, Gitschier J: Evidence for a third transcript from the human factor VIII gene. Genomics 14:585, 1992